CONSULTING SERVICES AGREEMENTConsulting Services Agreement • November 2nd, 2018 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
THIS CONSULTING SERVICES AGREEMENT (the “Agreement”) is made and entered into October 31, 2018(the “Effective Date”) by and between IDERA PHARMACEUTICALS, INC., having a place of business at 505 Eagleview Blvd., Suite 212, Exton, PA, USA (hereinafter referred to as “Idera”) and LOUIS J. ARCUDI, III, located at 4 Whitney Road, Hopedale, MA, 01747 (hereinafter referred to as the “Consultant”). Idera and Consultant may be referred to herein individually as a “Party” and collectively as the “Parties.”
SEPARATION AGREEMENT AND RELEASESeparation Agreement and Release • November 2nd, 2018 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This SEPARATION AND RELEASE AGREEMENT (this “Agreement”) is entered into by and between Idera Pharmaceuticals, Inc., having a place of business at 505 Eagleview Blvd., Suite 212, Exton, PA 19341 (the “Company”) and Louis J. Arcudi, III, located at 4 Whitney Road, Hopedale, MA 01747 (“Employee”).
